Abstract

ABSTRACTOf all live births with congenital anomalies, approximately one-third exhibit deformities of the head and face. Most craniofacial disorders are associated with defects in a migratory stem and progenitor cell population, which is designated the neural crest (NC). Musculocontractural Ehlers–Danlos syndrome (MCEDS) is a heritable connective tissue disorder with distinct craniofacial features; this syndrome comprises multiple congenital malformations that are caused by dysfunction of dermatan sulfate (DS) biosynthetic enzymes, including DS epimerase-1 (DS-epi1; also known as DSE). Studies in mice have extended our understanding of DS-epi1 in connective tissue maintenance; however, its role in fetal development is not understood. We demonstrate that DS-epi1 is important for the generation of isolated iduronic acid residues in chondroitin sulfate (CS)/DS proteoglycans in early Xenopus embryos. The knockdown of DS-epi1 does not affect the formation of early NC progenitors; however, it impairs the correct activation of transcription factors involved in the epithelial–mesenchymal transition (EMT) and reduces the extent of NC cell migration, which leads to a decrease in NC-derived craniofacial skeleton, melanocytes and dorsal fin structures. Transplantation experiments demonstrate a tissue-autonomous role for DS-epi1 in cranial NC cell migration in vivo. Cranial NC explant and single-cell cultures indicate a requirement of DS-epi1 in cell adhesion, spreading and extension of polarized cell processes on fibronectin. Thus, our work indicates a functional link between DS and NC cell migration. We conclude that NC defects in the EMT and cell migration might account for the craniofacial anomalies and other congenital malformations in MCEDS, which might facilitate the diagnosis and development of therapies for this distressing condition. Moreover, the presented correlations between human DS-epi1 expression and gene sets of mesenchymal character, invasion and metastasis in neuroblastoma and malignant melanoma suggest an association between DS and NC-derived cancers.

Highlights

  • The musculocontractural type of Ehlers–Danlos syndrome (MCEDS) is characterized by distinct craniofacial features, multisystem congenital malformations and progressive fragility of connective tissues (Zhang et al, 2010; Kosho, 2016)

  • Dse and Dsel are expressed in the early Xenopus embryo We have previously demonstrated that intra-blastocoelic injection of purified dermatan sulfate (DS), but not chondroitin sulfate (CS), stimulates posterior development, mesoderm formation and neuronal differentiation in an FGFdependent manner (Hou et al, 2007)

  • Biosynthesis of DS is not regulated by feedback We subsequently investigated whether the presence of iduronic acid (IdoA) in CS/ DS PGs affects the gene expression of DS epimerases. Quantitative real-time PCR (qPCR) analysis indicated no changes in the Dse and Dsel mRNA levels in stage 18 cranial neural crest (CNC) explants of the Dse-morpholino oligonucleotides (MOs)- compared with the Dse5MM-MO-injected control embryos (Fig. S4)

Read more

Summary

Introduction

The musculocontractural type of Ehlers–Danlos syndrome (MCEDS) is characterized by distinct craniofacial features, multisystem congenital malformations and progressive fragility of connective tissues (Zhang et al, 2010; Kosho, 2016) This rare intractable disorder is caused by recessive loss-of-function mutations in genes that encode dermatan sulfate (DS) biosynthetic enzymes, including dermatan 4-O-sulfotransferase 1 (CHST14) and DS epimerase-1 (DS-epi). DS-epi, which was originally referred to as squamous cell carcinoma antigen recognized by cytotoxic T lymphocytes 2 (SART2) (Nakao et al, 2000; Maccarana et al, 2006), is overexpressed in all tumors and functionally linked to the tumorigenic properties of esophagus squamous cell carcinoma that involve cell migration (Thelin et al, 2012) It is not clear how a modified CS/DS chain leads to developmental abnormalities and malignancy

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call